Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIV(mac251) at Challenge Exposure

We used the simian immunodeficiency virus mac251 (SIV(mac251)) macaque model to study the effect of the dose of mucosal exposure on vaccine efficacy. We immunized macaques with a DNA prime followed by SIV gp120 protein immunization with ALVAC-SIV and gp120 in alum, and we challenged them with SIV(ma...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vaccari, Monica, Keele, Brandon F., Bosinger, Steven E., Doster, Melvin N., Ma, Zhong-Min, Pollara, Justin, Hryniewicz, Anna, Ferrari, Guido, Guan, Yongjun, Forthal, Donald N., Venzon, David, Fenizia, Claudio, Morgan, Tia, Montefiori, David, Lifson, Jeffrey D., Miller, Chris J., Silvestri, Guido, Rosati, Margherita, Felber, Barbara K., Pavlakis, George N., Tartaglia, James, Franchini, Genoveffa
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2013
Teme:
Vaccines and Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3592147/
https://ncbi.nlm.nih.gov/pubmed/23325681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02863-12
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items